Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171938
Status:
TERMINATED
Last Update Posted:
2017-02-24
First Post:
2005-09-13
Brief Title:
Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR Platelet Derived Growth Factor Receptors
Sponsor:
Organization:
Novartis